SingHealth S’pore ties up with Delmege
Singapore’s largest integrated health care provider, Sing Health
which has two tertiary -level hospitals and five specialty centres, has
tied up with Delmege Medical (Pvt) Ltd, a part of the Delmege Forsyth
Group which has been in existence for over 150 years, where Delmege
Medical will be the local representative for SingHealth in Sri Lanka.
 “As its local representative Delmege Medical (PVt) Ltd will offer
required patient information about medical treatment at any SingHealth
facility to all its local customers who wish to be treated by the
SingHealth group of hospitals by calling over at its office at 101,
Vinayalankara Mawatha or calling on its hot line. We will also
facilitate the process and extend all help to those who wish to avail
themselves of this service,” Delmege Medical Director Kavinda Makalande
said.
The two tertiary level hospitals within the SingHealth Group are
Singapore General Hospital and KK Women’s and Children’s Hospital.
The Specialty Centres are respectively the National Cancer Institute
Singapore, National Heart Centre Singapore, National Neuroscience
Institute, Singapore National Eye Centre and the National Dental Centre
Singapore.
SingHealth offers multi disciplinary, integrated care and is
recognized for new breakthrough treatment in the region.
Each year SingHealth performs over 200,000 surgeries and handles
about 4.5 million patient visits.
SingHealth was the first healthcare facility in Asia Pacific to use
3D Fluoroscopy with stealth navigation (Medtronic O -arm), while the
Singapore General Hospital offers spine and orthopaedic patients less
invasive surgery, faster recovery time and improved out come.
The Singapore General Hospital has also performed the world’s first
unrelated cord blood stem cell transplant as well as the first cord
blood transplant for Thalassaemia patients.
The Breast Centre at the KK Women’s and Children’s Hospital, was the
first in the world to use FDA- approved Computed Radiography for
phosphor plate mammography
|
